COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial
JAMA
.
2022 Jan 11;327(2):115.
doi: 10.1001/jama.2021.24118.
Author
Jennifer Abbasi
PMID:
35015052
DOI:
10.1001/jama.2021.24118
No abstract available
Publication types
News
MeSH terms
Adjuvants, Vaccine
COVID-19 / prevention & control*
COVID-19 Vaccines / immunology*
Humans
T-Lymphocytes / immunology*
Substances
Adjuvants, Vaccine
COVID-19 Vaccines